1.1. Scope of the report

1.2. Market segment analysis

2.1 Research data source 

2.1.1 Secondary data

2.1.2 Primary data

2.1.3 SPER’s internal database

2.1.4 Premium insight from KOL’s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges 

4.2. COVID-19 Impacts of the Australia Pharmacy Retail Market 

5.1. SWOT analysis 

5.1.1 Strengths 

5.1.2 Weaknesses 

5.1.3 Opportunities

5.1.4 Threats

5.2. PESTEL analysis 

5.2.1 Political landscape

5.2.2 Economic landscape

5.2.3 Social landscape 

5.2.4 Technological landscape 

5.2.5 Environmental landscape 

5.2.6 Legal landscape 

5.3. PORTER’S five forces analysis 

5.3.1 Bargaining power of suppliers 

5.3.2 Bargaining power of Buyers 

5.3.3 Threat of Substitute 

5.3.4 Threat of new entrant 

5.3.5 Competitive rivalry

5.4. Heat map analysis

6.1 Australia Pharmacy Retail Manufacturing Base Distribution, Sales Area, Product Type 

6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Australia Pharmacy Retail Market 

7.1 Organized

7.1.1 Prescribed Drugs

7.1.2 Over-the-Counter

7.1.3 Non-Pharmaceutical Products

7.1.4 Medical Equipment

7.2 Unorganized

7.2.1 Prescribed Drugs

7.2.2 Over-the-Counter

7.2.3 Non-Pharmaceutical Products

7.2.4 Medical Equipments

8.1 Prescribed Drugs

8.2 Over-The-Counter

8.3 Non-Pharmaceutical Products

8.4 Medical Equipment

9.1 Community Pharmacies

9.2 Discount Pharmacies

9.3 Hospital Pharmacies

10.1 Patented Drugs

10.2 Generics

11.1 Anti-Infective

11.2 Cardiovascular

11.3 Central Nervous System

11.4 Pain

11.5 Vitamins/Minerals/Nutrients

11.6 Antibiotics

11.7 Respiratory

11.8 Gastro Intestinal

11.9 Gynaecology

11.10 Others

12.1 Australia Pharmacy Retail Size and Market Share by Region (2019-2025)

12.2 Australia Pharmacy Retail Size and Market Share by Region (2026-2032)

12.3 New South Wales

12.4 Queensland

12.5 South Australia

12.6 Tasmania 

12.7 Victoria

12.8 Western Australia 

12.9 Others

13.1 Corum Health

13.1.1 Company details 

13.1.2 Financial outlook

13.1.3 Product summary 

13.1.4 Recent developments

13.2 FRED ID

13.2.1 Company details 

13.2.2 Financial outlook

13.2.3 Product summary 

13.2.4 Recent developments

13.3 Minfos

13.3.1 Company details 

13.3.2 Financial outlook

13.3.3 Product summary 

13.3.4 Recent developments

13.4 Mountaintop Solutions

13.4.1 Company details 

13.4.2 Financial outlook

13.4.3 Product summary 

13.4.4 Recent developments

13.5 Posworks

13.5.1 Company details 

13.5.2 Financial outlook

13.5.3 Product summary 

13.5.4 Recent developments

13.6 RxOne

13.6.1 Company details 

13.6.2 Financial outlook

13.6.3 Product summary 

13.6.4 Recent developments

13.7 Simple Retail

13.7.1 Company details 

13.7.2 Financial outlook

13.7.3 Product summary 

13.7.4 Recent developments

13.8 Zsoftware

13.8.1 Company details 

13.8.2 Financial outlook

13.8.3 Product summary 

13.8.4 Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.